
Carta Healthcare Secures $18.25 Million for AI-Powered Clinical Data Solutions
Carta Healthcare has secured $18.25 million in Series B1 funding to advance its AI-powered clinical data abstraction and analytics services, announced in a press release. The investment round was led by UPMC Enterprises, with participation from several strategic investors, including MemorialCare Innovation Fund and Rex Health Ventures.
The funding will enable Carta Healthcare to expand its customer base, particularly in the life sciences sector, and enhance its AI-driven solutions that streamline clinical data abstraction. This comes after the company's acquisition of Realyze Intelligence, which uses AI to analyze structured and unstructured data for clinical trials and research studies.
Brent Burns, Executive Vice President at UPMC Enterprises, highlighted the importance of Carta Healthcare's technology in addressing the challenges of clinical data abstraction and patient trial matching. The investment aims to support the company's mission to provide actionable insights that improve patient care and operational efficiency in healthcare systems.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
More from: Funding
Statsig Secures $100M Series C Funding at $1.1B Valuation
Clarium Secures $27M to Enhance AI Supply Chain Platform
Echo360 Acquires GoReact to Enhance AI Video Assessment
Revelo Acquires Alto and Paretisa Amid Rising AI Talent Demand
Jozu Secures $4 Million to Expand AI Orchestration Platform
Subscribe to Daily AI Brief
Daily report covering major AI developments and industry news, with both top stories and complete market updates
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more